How Much Did Butterfly Network Raise? Headquarters, Funding & Key Investors

Butterfly Network has raised $605.6 million across multiple rounds, beginning with early seed funding in 2011 and expanding through a $100M venture round in 2014, a major $250M Series D in 2018 valuing the company at $1.25B, and a $175M Post-IPO round in 2021. Additional capital came from a $5M Gates Foundation grant in 2022 and $75.6M Post-IPO funding in 2025. Backed by investors like Fidelity, Tenet Healthcare, and Fosun Pharma, Butterfly Network’s Ultrasound-on-Chip™ innovation helped it scale into a global, publicly traded medical imaging leader.

How Much Did Butterfly Network Raise? Funding & Key Investors

Butterfly Network develops portable, chip-based ultrasound devices built to democratize medical imaging. The company disrupted traditional ultrasound by creating Butterfly iQ, a handheld, whole-body imaging device powered by its proprietary Ultrasound-on-Chip™ semiconductor platform.

Serving clinicians across emergency care, obstetrics, cardiology, and primary care, Butterfly’s solutions improve diagnostic accessibility and reduce equipment costs.

Butterfly continues to expand its portfolio with next-generation imaging and monitoring technologies.

What Is Butterfly Network and What Does It Do?

Butterfly Network, founded in 2011 by Jonathan M. Rothberg, Nevada Sanchez, and Tyler S. Ralston, is headquartered in Burlington, Massachusetts. The company specializes in bringing advanced ultrasound imaging to clinicians through semiconductor-based, handheld devices.

Butterfly Network employs 225 employees, offering the world’s first single-probe, whole-body ultrasound system built on Ultrasound-on-Chip technology.

Its platform supports diagnostic imaging across obstetrics, cardiac care, vascular health, emergency medicine, and more. By replacing multiple bulky machines with a single portable device, Butterfly Network aims to make high-quality imaging affordable and globally accessible.

How Much Funding Has Butterfly Network Raised?

1. Venture Round

Amount Raised: $100M
Date: November 2014
Motivation: To advance product development and scale engineering.

2. Series D

Amount Raised: $250M
Date: September 2018
Lead Investors: Fidelity
Motivation: To expand the global distribution of Butterfly iQ and accelerate commercialization.

3. Post-IPO Equity

Amount Raised: $175M
Date: February 2021
Motivation: To support new product development and international expansion.

4. Grant (Prize Money)

Amount Raised: $5M
Date: March 2022
Lead Investors: Bill & Melinda Gates Foundation
Motivation: To advance global health initiatives and expand medical imaging access.

5. Post-IPO Equity

Amount Raised: $75.6M
Date: January 2025
Motivation: To enhance product lines and enter additional markets.

Total Funding Raised: $605.6 Million

Latest Funding Date: January 2025

Key Investors

1. Bill & Melinda Gates Foundation

Details: One of the world’s largest philanthropic organizations focused on global health and development.
Investment Focus Areas: Global health, education, and biotechnology.
Notable Investments: Gavi, CureVac, Impossible Foods.

2. Tenet Healthcare Corporation

Details: Multinational healthcare services provider operating hospitals and surgical centers.
Investment Focus Areas: Hospital systems, medical services, patient care technologies.
Notable Investments: Conifer Health Solutions, USPI.

3. Fidelity

Details: Global investment management firm with a diversified portfolio across industries.
Investment Focus Areas: Technology, healthcare, and financial services.
Notable Investments: Uber, Airbnb, SpaceX.

4. Fosun Pharma

Details: Chinese pharmaceutical and healthcare firm with global operations.
Investment Focus Areas: Healthcare, biotech, medical devices.
Notable Investments: Gland Pharma, Henlius Biotech.

Where Is Butterfly Network’s Headquarters?

Butterfly Network is headquartered in Burlington, Massachusetts, a hub for healthcare innovation with strong access to clinical institutions, engineering talent, and advanced R&D facilities. Its strategic location supports collaboration with hospitals and research laboratories.

What’s Next for Butterfly Network?

Butterfly Network is expanding its reach into emerging markets, focusing on improving global diagnostic access. The company is developing advanced imaging tools, including a wearable monitoring patch and an ingestible diagnostic pill for cancer detection. With strong investor backing and rising demand for point-of-care imaging, Butterfly aims to broaden international distribution, deepen AI-powered diagnostics, and strengthen partnerships in low-resource healthcare environments.

Get Investor & Funding Insights with TexAu

TexAu helps sales and business teams uncover detailed fundraising information on companies like Butterfly Network. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.

Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.